Aytu biopharma announces issuance of first u.s. patent supporting healight ultraviolet-a respiratory catheter

Englewood, co / accesswire / november 23, 2021 / aytu biopharma, inc. (nasdaq:aytu), a specialty pharmaceutical company focused on commercializing novel therapeutics and consumer healthcare products, announced that today the united states patent and trademark office (uspto) has issued a u.s. patent for the healight™ ultraviolet-a light-based respiratory catheter. u.s. patent number 11,179,575, titled "internal ultraviolet therapy," is the first issued patent protecting the healight investigational device and covers methods of treating a patient for an infectious condition inside the patient's body through the insertion of a uv-light-emitting delivery tube inside a respiratory cavity of the patient at specific uv-a light wavelengths.
AYTU Ratings Summary
AYTU Quant Ranking